STOCK TITAN

Talphera (NASDAQ: TLPH) faces Nasdaq minimum bid-price deficiency notice

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Talphera, Inc. reported that Nasdaq has notified the company it is out of compliance with the exchange’s minimum bid price rule, which requires a closing bid of at least $1.00 per share for 30 consecutive business days. The company’s Nasdaq Capital Market listing is not immediately affected.

Talphera has 180 calendar days, until September 7, 2026, to regain compliance by maintaining a closing bid of at least $1.00 for ten consecutive business days. If it fails to do so, it may qualify for an additional 180-day period or face potential delisting if it cannot demonstrate a viable plan to cure the deficiency.

Positive

  • None.

Negative

  • Nasdaq bid-price deficiency and delisting risk: Talphera received a Nasdaq notice that its stock no longer meets the $1.00 minimum bid price requirement, creating a defined timeline to cure the issue and potential delisting if compliance is not regained.

Insights

Nasdaq bid-price noncompliance introduces listing risk but allows cure periods.

Talphera has been notified that its share price no longer meets Nasdaq’s $1.00 minimum bid requirement. The notice alone does not remove the stock from the Nasdaq Capital Market, but it formally starts a compliance clock and flags sustained price weakness.

The company has 180 days, until September 7, 2026, to achieve a closing bid of at least $1.00 for ten consecutive business days. If other listing thresholds are met, it may obtain a second 180‑day window, potentially using a reverse stock split to restore compliance.

If Talphera cannot satisfy the minimum bid price or secure additional time, Nasdaq may move to delist the shares, which would shift trading to less liquid venues. The company states it will monitor its stock price and evaluate available options under the rules.

false 0001427925 0001427925 2026-03-11 2026-03-11
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): March 11, 2026
 

 
TALPHERA, INC.
(Exact name of registrant as specified in its charter)
 

 
Delaware
001-35068
41-2193603
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
   
1850 Gateway Drive, Suite 175
San Mateo, California
94404
(Address of Principal Executive Offices)
(Zip Code)
 
Registrants telephone number, including area code: (650) 216-3500
 

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
     
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Common Stock, $0.001 par value
TLPH
The Nasdaq Capital Market
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
 
Item 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
 
On March 11, 2026, Talphera, Inc., (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days.
 
The Notice does not impact the listing of the Company’s common stock on The Nasdaq Capital Market at this time. In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has 180 calendar days to regain compliance with the minimum bid price requirement. To regain compliance, the closing bid price of the Company’s common stock must be at least $1.00 per share for a minimum of ten consecutive business days before September 7, 2026. In the event that the Company does not regain compliance within this 180-day period, the Company may be eligible to seek an additional compliance period of 180 calendar days if it meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the minimum bid price requirement, and provides written notice to Nasdaq of its intent to cure the deficiency during this second compliance period by effecting a reverse stock split if necessary. However, if it appears to the Nasdaq staff that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice to the Company that its common stock will be subject to delisting.
 
The Company intends to actively monitor the closing bid price of its common stock and will evaluate available options to regain compliance with the minimum bid price requirement.
 
The Company, by filing this Form 8-K, discloses its receipt of the Notice from Nasdaq in accordance with Listing Rule 5810(b).
 
Forward-Looking Statements
 
Certain of the statements made in this report are forward-looking, such as those, among others, relating to the Company’s ability to regain compliance with the Minimum Bid Price and the Company’s intentions to actively monitor the closing bid price of its common stock and to evaluate available options to regain compliance with the minimum bid price requirement within the required time period. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. More information about the risks and uncertainties faced by the Company is contained under the caption “Risk Factors” in the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 12, 2025. You are cautioned not to place undue reliance on forward-looking statements which are current only as of the date hereof. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
             
Date: March 13, 2026
     
Talphera, Inc.
       
       
By:
 
/s/ Raffi Asadorian
       
Name:
 
Raffi Asadorian
       
Title:
 
Chief Financial Officer
 
 

FAQ

What Nasdaq notification did Talphera (TLPH) receive about its stock?

Talphera received a written notice from Nasdaq stating its common stock no longer meets the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). The deficiency followed at least 30 consecutive business days with a closing bid below that threshold.

Does the Nasdaq bid-price notice immediately delist Talphera (TLPH) shares?

The notice does not immediately delist Talphera’s common stock from the Nasdaq Capital Market. It starts a 180-day compliance period during which the company can regain compliance before Nasdaq considers further actions, including potential delisting.

How can Talphera (TLPH) regain compliance with Nasdaq’s $1.00 bid rule?

To regain compliance, Talphera’s closing bid price must be at least $1.00 per share for a minimum of ten consecutive business days before September 7, 2026. Meeting this standard would return the company to good standing under Nasdaq Listing Rule 5550(a)(2).

What happens if Talphera (TLPH) does not regain compliance within 180 days?

If Talphera fails to regain compliance within 180 days, it may qualify for an additional 180-day period if other listing standards are met. Otherwise, Nasdaq may notify the company that its common stock will be subject to delisting from the Nasdaq Capital Market.

Could Talphera (TLPH) use a reverse stock split to address Nasdaq’s notice?

The company notes it could seek a second 180-day compliance period by meeting other listing standards and stating its intent to cure the deficiency, potentially by effecting a reverse stock split if necessary. This is one option it may evaluate under Nasdaq rules.

What actions does Talphera (TLPH) plan following the Nasdaq deficiency notice?

Talphera states it will actively monitor the closing bid price of its common stock and evaluate available options to regain compliance with Nasdaq’s minimum bid price requirement within the allowed timeframe, consistent with the listing rules and applicable regulations.

Filing Exhibits & Attachments

4 documents
Talphera Inc

NASDAQ:TLPH

View TLPH Stock Overview

TLPH Rankings

TLPH Latest News

TLPH Latest SEC Filings

TLPH Stock Data

37.76M
30.68M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
SAN MATEO